Enterprise Solutions Webinars
-
From Concept To Market: Mammalian Protein Development And Manufacturing
10/16/2025
With proven expertise in process development, optimization, and CGMP manufacturing, Avid offers end-to-end CDMO solutions backed by flexible capacity designed to scale with program needs.
-
Mabion Capacity Update October 2025: Analytical Services
10/15/2025
We offer an end-to-end solution, covering every stage of biologic drug development, from early clone selection and small-scale manufacturing to process scale-up, large-scale production, and quality control.
-
KBI Biopharma Capacity Update October 2025: Analytical Services
10/15/2025
Leveraging decades of expertise, analytical capabilities, and regulatory knowledge, we deliver phase-appropriate solutions that streamline development, reduce risk, and accelerate timelines from discovery through commercialization.
-
Alcami Capacity Update October 2025: Analytical Services
10/15/2025
Whether you're preparing for IND, scaling commercial operations, or navigating complex regulatory pathways, gain actionable strategies and updates to help you move forward with confidence.
-
Abzena Capacity Update October 2025: ADC
10/15/2025
Explore ThioBridge™ as an efficient site-specific conjugation technology to generate ADCs and other conjugate modalities, such as AOCs and conjugates for diagnostic applications.
-
Integrated Manufacturing To Mitigate CMC Risks, Simplify Commercial Supply
10/15/2025
Leveraging cross-functional coordination between sites, harmonized tech transfers, one quality system, and synchronized team activities can streamline regulatory submissions and deliver high-quality commercial outcomes.
-
Supply Resiliency For Bioprocessing Amid Global Volatility
10/2/2025
Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.
-
Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency
9/25/2025
Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.
-
Mobilizing Science, Partnership, And Capability To Develop A Gene Therapy In 14 Months
9/17/2025
Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.
-
Transforming Nanoparticles By Continuous Manufacturing
9/13/2025
Discover how continuous manufacturing of nanoparticles can improve process efficiency, reduce costs, and increase the quality of the final drug product.